Exhausted from Chronic Obstructive Pulmonary Disease?
There are Options! COPD Clinical Trials might help you!
Chronic Obstructive Pulmonary Disease commonly known as COPD is a group of diseases that block our airways, leading to breathing difficulties. It was the third leading cause of death in 2019, with 65 million people suffering from moderate to severe COPD, as of now. Despite the current treatment options, there is an unmet need for deceleration of COPD progression in the medical realm.
Revive Research Institute is one of the leading centers conducting COPD Clinical Trials. The clinical research studies are directed to provide potential treatment options for people suffering from moderate to severe COPD.
Eligibility criteria to enroll in the COPD Clinical Trials study is as follows:
- Male or female between 40 to 90 years of age
- Documented history of COPD for at least 12 months
- Currently on a stable dose of inhaled corticosteroids
Men and women who suffer from Chronic Obstructive Pulmonary Disease (COPD) and fulfill the above criteria are eligible to participate in this COPD Research study.